Growth Metrics

Idexx Laboratories (IDXX) Net Cash Flow (2016 - 2026)

Idexx Laboratories has reported Net Cash Flow over the past 17 years, most recently at -$28.1 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 164.83% year-over-year to -$28.1 million; the TTM value through Dec 2025 reached -$119.4 million, up 23.53%, while the annual FY2025 figure was -$119.4 million, 23.53% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$28.1 million at Idexx Laboratories, down from $44.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $201.6 million in Q3 2023 and troughed at -$122.0 million in Q1 2025.
  • A 5-year average of -$9.7 million and a median of -$9.8 million in 2022 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 7091.35% in 2022 and later tumbled 3021.01% in 2024.
  • Year by year, Net Cash Flow stood at $104000.0 in 2021, then skyrocketed by 7091.35% to $7.5 million in 2022, then soared by 1472.03% to $117.6 million in 2023, then crashed by 109.02% to -$10.6 million in 2024, then crashed by 164.83% to -$28.1 million in 2025.
  • Business Quant data shows Net Cash Flow for IDXX at -$28.1 million in Q4 2025, $44.2 million in Q3 2025, and -$13.5 million in Q2 2025.